Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T17:03:25.236Z.
Calculation as of: 2026-10-06T17:03:25.236Z.
Quote observation: 2026-10-06T17:00:51.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b626f321e8bf7fc1aa576344fb562ad2ba7a1b85fa36d8388ebfe6a76482c652
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
NewGenIvf Group Limited
Market Cap
$6159.00
EBITDA Yield
N/A
Market Cap
$30755.00
EBITDA Yield
N/A
| NAME | MARKET CAP | EBITDA YIELD |
|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6159.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30755.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61495.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72318.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95424.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109065.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | N/A |
| HCW Biologics Inc. (HCWB)vs › | $559702.00 | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
